BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9482662)

  • 1. Multiple regions of ligand discrimination revealed by analysis of chimeric parathyroid hormone 2 (PTH2) and PTH/PTH-related peptide (PTHrP) receptors.
    Clark JA; Bonner TI; Kim AS; Usdin TB
    Mol Endocrinol; 1998 Feb; 12(2):193-206. PubMed ID: 9482662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors.
    Hoare SR; Usdin TB
    Curr Pharm Des; 2001 May; 7(8):689-713. PubMed ID: 11375776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regions in rat and human parathyroid hormone (PTH) 2 receptors controlling receptor interaction with PTH and with antagonist ligands.
    Goold CP; Usdin TB; Hoare SR
    J Pharmacol Exp Ther; 2001 Nov; 299(2):678-90. PubMed ID: 11602681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of parathyroid hormone (PTH)/secretin receptor chimeras differentiates the role of functional domains in the pth/ pth-related peptide (PTHrP) receptor on hormone binding and receptor activation.
    Vilardaga JP; Lin I; Nissenson RA
    Mol Endocrinol; 2001 Jul; 15(7):1186-99. PubMed ID: 11435617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The extracellular amino-terminal region of the parathyroid hormone (PTH)/PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-(1-34).
    Jüppner H; Schipani E; Bringhurst FR; McClure I; Keutmann HT; Potts JT; Kronenberg HM; Abou-Samra AB; Segre GV; Gardella TJ
    Endocrinology; 1994 Feb; 134(2):879-84. PubMed ID: 8299582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmembrane residues together with the amino terminus limit the response of the parathyroid hormone (PTH) 2 receptor to PTH-related peptide.
    Turner PR; Mefford S; Bambino T; Nissenson RA
    J Biol Chem; 1998 Feb; 273(7):3830-7. PubMed ID: 9461563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberoinfundibular peptide 39 binds to the parathyroid hormone (PTH)/PTH-related peptide receptor, but functions as an antagonist.
    Jonsson KB; John MR; Gensure RC; Gardella TJ; Jüppner H
    Endocrinology; 2001 Feb; 142(2):704-9. PubMed ID: 11159842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histidine at position 5 is the specificity "switch" between two parathyroid hormone receptor subtypes.
    Behar V; Nakamoto C; Greenberg Z; Bisello A; Suva LJ; Rosenblatt M; Chorev M
    Endocrinology; 1996 Oct; 137(10):4217-24. PubMed ID: 8828480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residues in the membrane-spanning and extracellular loop regions of the parathyroid hormone (PTH)-2 receptor determine signaling selectivity for PTH and PTH-related peptide.
    Bergwitz C; Jusseaume SA; Luck MD; Jüppner H; Gardella TJ
    J Biol Chem; 1997 Nov; 272(46):28861-8. PubMed ID: 9360953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-receptor interactions at the parathyroid hormone receptors: subtype binding selectivity is mediated via an interaction between residue 23 on the ligand and residue 41 on the receptor.
    Mann R; Wigglesworth MJ; Donnelly D
    Mol Pharmacol; 2008 Sep; 74(3):605-13. PubMed ID: 18539702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular determinants of tuberoinfundibular peptide of 39 residues (TIP39) selectivity for the parathyroid hormone-2 (PTH2) receptor. N-terminal truncation of TIP39 reverses PTH2 receptor/PTH1 receptor binding selectivity.
    Hoare SR; Clark JA; Usdin TB
    J Biol Chem; 2000 Sep; 275(35):27274-83. PubMed ID: 10854439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human PTH2 receptor: binding and signal transduction properties of the stably expressed recombinant receptor.
    Behar V; Pines M; Nakamoto C; Greenberg Z; Bisello A; Stueckle SM; Bessalle R; Usdin TB; Chorev M; Rosenblatt M; Suva LJ
    Endocrinology; 1996 Jul; 137(7):2748-57. PubMed ID: 8770894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcript expression of the tuberoinfundibular peptide (TIP)39/PTH2 receptor system and non-PTH1 receptor-mediated tonic effects of TIP39 and other PTH2 receptor ligands in renal vessels.
    Eichinger A; Fiaschi-Taesch N; Massfelder T; Fritsch S; Barthelmebs M; Helwig JJ
    Endocrinology; 2002 Aug; 143(8):3036-43. PubMed ID: 12130570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist-dependent phosphorylation of the parathyroid hormone/parathyroid hormone-related peptide receptor.
    Qian F; Leung A; Abou-Samra A
    Biochemistry; 1998 May; 37(18):6240-6. PubMed ID: 9572838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative interaction of arginine-19 and the N-terminal signaling domain in the affinity and potency of parathyroid hormone.
    Tsomaia N; Shimizu M; Shimizu N; Gardella TJ; Mierke DF
    Biochemistry; 2004 Mar; 43(12):3459-70. PubMed ID: 15035617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the extracellular regions of the parathyroid hormone (PTH)/PTH-related peptide receptor in hormone binding.
    Lee C; Gardella TJ; Abou-Samra AB; Nussbaum SR; Segre GV; Potts JT; Kronenberg HM; Jüppner H
    Endocrinology; 1994 Oct; 135(4):1488-95. PubMed ID: 7523099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sites of contact between the carboxyl-terminal binding domain of PTHrP-(1--36) analogs and the amino-terminal extracellular domain of the PTH/PTHrP receptor identified by photoaffinity cross-linking.
    Gensure RC; Gardella TJ; Jüppner H
    J Biol Chem; 2001 Aug; 276(31):28650-8. PubMed ID: 11356832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the ligand specificity of zebrafish parathyroid hormone (PTH) receptors: comparison of PTH, PTH-related protein, and tuberoinfundibular peptide of 39 residues.
    Hoare SR; Rubin DA; Jüppner H; Usdin TB
    Endocrinology; 2000 Sep; 141(9):3080-6. PubMed ID: 10965877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberoinfundibular peptide (7-39) [TIP(7-39)], a novel, selective, high-affinity antagonist for the parathyroid hormone-1 receptor with no detectable agonist activity.
    Hoare SR; Usdin TB
    J Pharmacol Exp Ther; 2000 Nov; 295(2):761-70. PubMed ID: 11046116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and functional expression of a complementary DNA for porcine parathyroid hormone/parathyroid hormone-related peptide receptor.
    Smith DP; Zhang XY; Frolik CA; Harvey A; Chandrasekhar S; Black EC; Hsiung HM
    Biochim Biophys Acta; 1996 Jul; 1307(3):339-47. PubMed ID: 8688470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.